• When people hear dosage, they often think of medication. • But dosage is a broader clinical concept. • It is the structure that makes an intervention legible to clinicians, payers, and regulators. • For VR therapy, dosage is the answer to simple questions that are still surprisingly inconsistent across studies and pilots. • The post From Pilots to Protocols: Why VR Therapy Needs Dosage Standards to Become Real Clinical Care appeared first on MedCity News .
Article Summaries:
- Summary
The article argues that virtual‑reality (VR) therapy must adopt standardized “dosage” protocols-beyond the usual medication concept-to transition from experimental pilots to routine clinical care. Dosage, defined as the structured parameters that make an intervention understandable to clinicians, payers, and regulators, remains inconsistently reported across VR studies. Without clear guidelines on session length, frequency, intensity, and progression, stakeholders cannot assess efficacy, cost, or safety. The piece calls for industry-wide consensus on VR dosage standards to ensure reliable, evidence‑based treatment and facilitate reimbursement and regulatory approval.
Sources: